Abstract
Background: COPD remains a common cause of morbidity and mortality worldwide. NIV has been well established as the gold standard therapy for treatment of acute decompensated respiratory failure complicating an acute exacerbation of COPD (AECOPD) with reduced mortality and intubation rates compared to standard therapy. Objective: to evaluate the predictors for the need for NIV in management of AECOPD.
Methods: Eighty adult patients previously diagnosed as COPD presented with AECOPD were assessed with recording of demographic and clinical data, arterial blood gases (ABGs), C-reactive protein (CRP), serum electrolytes (sodium (Na)&potassium (K)) with previously performed spirometry.
Results: The current study showed higher smoking frequency and smoking index in group II patients that were treated with NIV, BMI mean ± SD. was significantly higher in group I who were treated without need for NIV. Group II was presented by more frequent AECOPD, higher heart rate and respiratory rate and longer duration of hospital stay. More cases of group II showed positive CRP (60%) versus 46.7% of group I cases, while mean ± SD of CRP showed insignificant differences between both groups. Serum Na and K were significantly lower in group II. There was significant differences between both groups as regards PH and PaO2/FiO2 as these values were significantly lower in group II patients. Univariate regression analysis elucidated that higher smoking index (SI), PaCO2, and frequent AECOPD were independent positive predictors of the need for NIV in treating cases of AECOPD and higher PaO2 and PaO2/FiO2 were negative predictors of its requirement.
Conclusions: Higher smoking index and frequency, more frequent COPD exacerbations, higher heart rate and respiratory rate,lower serum electrolytes (Na & K),lower PH and PaO2/FiO2 can significantly indicate a more severe AECOPD and higher smoking index (SI), PaCO2, frequent AECOPD, or lower PaO2 and Pao2/FiO2 can be used as independent predictors for the need for NIV.
Keywords: COPD, AECOPD, NIV, ABGs, electrolytes, Na, K
References
- Shah NM., D'Cruz RF., Murphy PB. (2018).Update: non-invasive ventilation in chronic obstructive pulmonary disease. J Thorac Dis.; 10(1): S71–S79.
- Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and prevention of Chronic Obstructive Pulmonary Disease. Management of exacerbation. Pp 99. Barcelona, Spain:GOLD; 2018.
- Ramesh M., Banala R., Kumar K. (2016). Predictors for mechanical ventilation in acute exacerbation of COPD with respiratory failure. International Journal of General Medicine and Pharmacy (IJGMP); 5(5):15-20.
- ,Manfreda J., Warren CP., Hershfield ES., Harding GK., Nelson NA. (1987). Antibiotic therapy in exacrebations of chronic obstructive pulmonary disease. Ann Intern Med; 106(2): 196-204.
- Schiavo A., Renis M., Polverino M., Lanuzzi A., Polverino F. (2016). Acid-base balance, serum electrolytes and need for non-invasive ventilation in patients with hypercapnic acute exacerbation of chronic obstructive pulmonary disease admitted to an internal medicine ward. Multidisciplinary Respiratory Medicine; 11:23
- Franciosi LG., Page CP., Celli BR., Cazzola M., Walker MJ.,Danhof M., Robe KF., Pasqua OE. (2006). Markers of exacerbation severity in chronic obstructive pulmonary disease. Respiratory Research; 7(1):74.
- Vitacca M., Clini E., Porta R., Foglio K., Ambrosino N. (1996). Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation. EurRespir J; 9(7):1487-93.
- Laaban JP., Kouchakji B., Dore MF., Orvoen–Frija E., David P., Rochemaure J. (1993). Nutritional status of patients with COPD and acute respiratory failure. Chest; 103(5):1362-68.
- Rochester DF., Esau SA. (1984). Malnutrition and respiratory system. Chest; 85(3):411-15.
- Cao C., Wang R., Wang J., Bunjhoo H., Xu Y., Xiong W. (2010). Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-Analysis. PLOS ONE;7(8):e43892.
- Miravitlles M., Izquierdo I., Herrejon A., Torres JV., Baro E., Borja J., On behalf of the ESFERA investigators (2011). COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respiratory Medicine; 105(5):740-47.
- Gravil JH., Al-Rawas OA., Cotton MM., Flanigan U., Irwin A., Stevenson RD. (1998). Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service. Lancet; 351(9119):1853-55.
- Wang Y., Stavem K., Dahl FA., Humerfelt S., Haugen T. (2014). Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). International Journal of chronic obstructive pulmonary disease; 9:99-105.
- Chandra D., Guntupalli K., Guleria R. (2007). Hypotension is a predictor of mortality in acute exacerbation of chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 49:13-18.
- Milacic N., Milacic B., Milojkovic M., Ljubisavljevic S., Vodopic S., Hasanbegovic M., Durovic M. (2016). Correlation of C-Reactive Protein and COPD Severity. ActaClin Croat;55:41-48.
- Cano NJ., Pichard C., Eng HR., Court-Fortune I., Cynober L., Gerard-Boncompain M., Cuvelier A., Laaban J., Melchior J., Raphael J., Pison CM., The Clinical Research Group of the Societe Francophone de Nutrition Enterale et Parenterale (2004).C-Reactive Protein and Body Mass Index Predict Outcome in End-Stage Respiratory Failure. Chest; 126(2):540-46.
- Yang CT., Lin HC., Lin MC., Wang CH., Lee CH., Kuo HP. (1996). Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease. Eur J ClinPharmacol.; 49(5):476-82.
- Goli G., Mukka R., Sairi S. (2016). Study of serum electrolytes in acute exacerbation of chronic obstructive pulmonary disease patients. Int J Res Med Sci. ;4(8):3324-27.
Corresponding Author
Elham Abdelhady Abdelghany
Chest Department, Faculty of Medicine Minia University
DOI: https://dx.doi.org/10.18535/jmscr/v6i6.187
